Coronary

View the latest content related to this topic

News Daily News

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Trialists should focus less on physician-defined outcomes and more on what matters to patients, Mario Gaudino says.

Yael L. Maxwell

May 15, 2025

Slides

See all

Presentation EuroPCR 2025

Complete or culprit-only revascularisation in STEMI: 10-year outcome of DANAMI-3-PRIMULTI

Presenter: Thomas Engstrøm

May 22, 2025

Presentation EuroPCR 2025

A randomised trial of coronary function testing-guided treatment versus standard care in ANOCA

Presenter: Tim Van De Hoef

May 22, 2025

Presentation ACC 2025

Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial

Presenter: William Fearon

March 30, 2025

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Presentation ACC 2025

Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial

Presenter: Joo-Yong Hahn

March 29, 2025

News

See all

News Conference News EuroPCR 2025

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

By Yael L. Maxwell

May 23, 2025

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

By L.A. McKeown

May 22, 2025

News Conference News EuroPCR 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

By Yael L. Maxwell

May 20, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

By Michael O'Riordan

May 20, 2025

News Daily News

Whether Angio or CT Come First in Evaluating Chest Pain, QoL After Is Similar

By Yael L. Maxwell

May 20, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Coronary

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Slides

Complete or culprit-only revascularisation in STEMI: 10-year outcome of DANAMI-3-PRIMULTI

A randomised trial of coronary function testing-guided treatment versus standard care in ANOCA

Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial

News

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Whether Angio or CT Come First in Evaluating Chest Pain, QoL After Is Similar

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Coronary

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content